Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04204954
Other study ID # 201959B1
Secondary ID
Status Completed
Phase Phase 2/Phase 3
First received
Last updated
Start date May 6, 2019
Est. completion date December 13, 2019

Study information

Verified date April 2020
Source Hospital de La Luz
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Demodex blepharitis is a prevalent cause of comorbid infection among individuals undergoing cataract surgery. Several complications may arise in the postsurgical period from Staphylococcus or Streptococcus co-infections, as Demodex is a vector for these pathogens. Hence, prophylactic treatments before cataract surgery may lead to a reduction in complication rates. Since Demodex infestation and cataract surgery are two prevalent coexisting conditions in the general population, this study aims to test the effect of four combined treatments to eradicate or improve the Demodex infestation index before surgery. The investigators are conducting a single-blinded randomized trial of four therapies in participants undergoing cataract surgery. All participants will or are receiving daily eyelid cleansing bid and topical 0.3% ciprofloxacin q4h for three days added to the allocated treatment arm. Our four intervention groups are: [1] Blephaclean eye scrubs; [2] 50% dilution baby shampoo; [3] tea tree oil shampoo; [4]: topical 0.3% ciprofloxacin alone. To assess treatment efficacy, the investigators will perform eyelash hair epilation pre and postoperatively. The primary outcome is a change in the mean Demodex spp. infestation index. Also, a change in the crude number of Demodex (egg, larvae, nymph, or adult-form) spp. in eyelashes after one-week of therapy.


Recruitment information / eligibility

Status Completed
Enrollment 160
Est. completion date December 13, 2019
Est. primary completion date November 14, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Signed informed consent after explanation of the nature and possible consequences of the study.

- Clinical diagnosis of cataracts staged with Lens Opacity Classification System III based on the American Academy of Ophthalmology and the American Society of Cataract and Refractive Surgery guidelines.

- No topical antibiotic ointment therapy or eyelid cleansing in the past six months.

- No systemic antibiotic or antiparasite treatment in the past six months.

- No ocular comorbidities (other than cataracts)

- No systemic comorbidities.

Exclusion Criteria:

- Withdrawal from the study.

- Minimal changes based on the Lens Opacity Classification System III.

Study Design


Intervention

Other:
Tea Tree Oil Shampoo
Twice a day eyelid margin cleansing for three days.
Drug:
Ciprofloxacin Ophthalmic Ointment 0.3%
Applied topically in the eyelid margin every four hours for three days.
Other:
Baby shampoo
Twice a day eyelid margin cleansing for three days.
Blephaclean
Twice a day eyelid margin cleansing for three days.

Locations

Country Name City State
Mexico Hospital de la Luz Mexico City

Sponsors (8)

Lead Sponsor Collaborator
Hospital de La Luz Andric C. Perez-Ortiz, M.D., M.P.H., Azyadeh Camacho-Ordóñez, M.D., M.Sc.c., Bani Antonio-Aguirre, M.D., M.P.H.c., Claudia Palacio Pastrana, M.D., M.Sc., Cristina Mendoza-Velasquez, M.D., M.Sc., Hector Perez Cano, Ph.D., Samuel J. Avalos Lara, M.D.

Country where clinical trial is conducted

Mexico, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mean Demodex spp. infestation index by intervention group Number of demodex (egg, larvae, nymph, adult-form) spp. per eyelash (taken from epilation). One week.
Primary Crude count of Demodex spp. adult-forms (mites) in eyelashes by intervention group Number of demodex (egg, larvae, nymph, adult-form) spp. in total (taken from epilation). One week.
Secondary Endophthalmitis in the postoperative period. Number of cases diagnosed with endophthalmitis in the postoperative period. One week.
See also
  Status Clinical Trial Phase
Completed NCT04685538 - Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification. Phase 3
Recruiting NCT06060041 - IC-8 Apthera IOL New Enrollment Post Approval Study
Recruiting NCT05518539 - Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
Recruiting NCT05271942 - Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods N/A
Active, not recruiting NCT04778501 - PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia N/A
Completed NCT05062564 - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye N/A
Completed NCT03751033 - Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings N/A
Completed NCT02529488 - Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00 N/A
Completed NCT04539548 - A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract Phase 3
Completed NCT03740659 - Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery Phase 2
Completed NCT03494257 - Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification N/A
Completed NCT05119127 - Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome. N/A
Active, not recruiting NCT04271709 - Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT) N/A
Recruiting NCT03713268 - Intraoperative OCT Guidance of Intraocular Surgery II
Completed NCT03739528 - Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery Phase 3
Completed NCT02888210 - A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery Phase 3
Completed NCT03356847 - Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery N/A
Completed NCT04332640 - Clinical Evaluation of the Next Generation Phaco System N/A
Recruiting NCT03638726 - Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification Phase 4
Completed NCT03050697 - Evaluation of the Safety and Performance of the HARMONI® Toric Lens N/A